Regeneron, White House and drug pricing deal
Digest more
By Sriparna Roy WASHINGTON, April 23 (Reuters) - The White House will announce a drug pricing deal with Regeneron Pharmaceuticals at an event on Thursday afternoon, White House press secretary Karoline Leavitt said in a post on X.
Trump’s new big pharma deal announced today aims to lower drug prices nationwide, expand Medicaid savings, and cut costs for key medications.